NASDAQ:AVAH Aveanna Healthcare (AVAH) Stock Forecast, Price & News $1.31 +0.07 (+5.65%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$1.25▼$1.3350-Day Range$0.98▼$1.3152-Week Range$0.67▼$3.15Volume183,945 shsAverage Volume199,908 shsMarket Capitalization$247.41 millionP/E RatioN/ADividend YieldN/APrice Target$2.34 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Aveanna Healthcare MarketRank™ ForecastAnalyst RatingHold1.88 Rating ScoreUpside/Downside79.0% Upside$2.34 Price TargetShort InterestBearish6.00% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.03Based on 3 Articles This WeekInsider TradingAcquiring Shares$5,780 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.15) to ($0.10) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.91 out of 5 starsMedical Sector622nd out of 983 stocksHome Health Care Services Industry7th out of 7 stocks 2.9 Analyst's Opinion Consensus RatingAveanna Healthcare has received a consensus rating of Hold. The company's average rating score is 1.88, and is based on 1 buy rating, 5 hold ratings, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.34, Aveanna Healthcare has a forecasted upside of 79.0% from its current price of $1.31.Amount of Analyst CoverageAveanna Healthcare has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted6.00% of the float of Aveanna Healthcare has been sold short.Short Interest Ratio / Days to CoverAveanna Healthcare has a short interest ratio ("days to cover") of 6.4.Change versus previous monthShort interest in Aveanna Healthcare has recently increased by 33.94%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAveanna Healthcare does not currently pay a dividend.Dividend GrowthAveanna Healthcare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVAH. Previous Next 2.8 News and Social Media Coverage News SentimentAveanna Healthcare has a news sentiment score of 1.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Aveanna Healthcare this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for AVAH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Aveanna Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aveanna Healthcare insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,780.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 6.90% of the stock of Aveanna Healthcare is held by insiders.Percentage Held by Institutions91.65% of the stock of Aveanna Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Aveanna Healthcare are expected to grow in the coming year, from ($0.15) to ($0.10) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aveanna Healthcare is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aveanna Healthcare is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Aveanna Healthcare (NASDAQ:AVAH) StockAveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.Read More Receive AVAH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address AVAH Stock News HeadlinesMay 22, 2023 | americanbankingnews.comBrokerages Set Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Target Price at $2.26May 17, 2023 | finance.yahoo.comShareholders in Aveanna Healthcare Holdings (NASDAQ:AVAH) are in the red if they invested a year agoJune 3, 2023 | Behind the Markets (Ad)Why Your IRA Could Crash on June 16thChina will attack Taiwan as soon as June 16th, 2023. The stock market will crash at least 35% when China makes their move.May 15, 2023 | markets.businessinsider.comRBC Capital Sticks to Its Hold Rating for Aveanna Healthcare Holdings (AVAH)May 15, 2023 | msn.comRBC Capital Reiterates Aveanna Healthcare Holdings (AVAH) Sector Perform RecommendationMay 14, 2023 | americanbankingnews.comAveanna Healthcare (NASDAQ:AVAH) Releases Quarterly Earnings Results, Hits EstimatesMay 13, 2023 | americanbankingnews.comAveanna Healthcare (NASDAQ:AVAH) Lowered to Market Perform at Raymond JamesMay 12, 2023 | msn.comCredit Suisse Reiterates Aveanna Healthcare Holdings (AVAH) Underperform RecommendationJune 3, 2023 | Behind the Markets (Ad)Why Your IRA Could Crash on June 16thChina will attack Taiwan as soon as June 16th, 2023. The stock market will crash at least 35% when China makes their move.May 12, 2023 | msn.comRaymond James Downgrades Aveanna Healthcare Holdings (AVAH)May 12, 2023 | markets.businessinsider.comBank of America Securities Keeps Their Sell Rating on Aveanna Healthcare Holdings (AVAH)May 12, 2023 | markets.businessinsider.comAveanna Healthcare Holdings (AVAH) Gets a Sell from Credit SuisseMay 12, 2023 | msn.comRecap: Aveanna Healthcare Hldgs Q1 EarningsMay 12, 2023 | finance.yahoo.comQ1 2023 Aveanna Healthcare Holdings Inc Earnings CallMay 11, 2023 | finance.yahoo.comAveanna Healthcare (AVAH) Reports Q1 Loss, Tops Revenue EstimatesMay 11, 2023 | finanznachrichten.deAveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter 2023 Financial ResultsMay 11, 2023 | finance.yahoo.comAveanna Healthcare Holdings Announces First Quarter 2023 Financial ResultsMay 9, 2023 | americanbankingnews.comAveanna Healthcare (AVAH) Set to Announce Earnings on ThursdayMay 4, 2023 | finance.yahoo.comEarnings Preview: Aveanna Healthcare (AVAH) Q1 Earnings Expected to DeclineApril 27, 2023 | americanbankingnews.comAveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives $2.34 Average Target Price from BrokeragesApril 24, 2023 | finance.yahoo.comAveanna Announces First Quarter 2023 Earnings Release Date and Conference CallApril 8, 2023 | finance.yahoo.comAveanna Healthcare Holdings (NASDAQ:AVAH) May Have Issues Allocating Its CapitalMarch 21, 2023 | americanbankingnews.comRaymond James Trims Aveanna Healthcare (NASDAQ:AVAH) Target Price to $3.00March 18, 2023 | seekingalpha.comAveanna Healthcare Holdings Inc. (AVAH) Q4 2022 Earnings Call TranscriptMarch 18, 2023 | finance.yahoo.comAveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Q4 2022 Earnings Call TranscriptMarch 17, 2023 | benzinga.comAveanna Healthcare Hldgs Earnings Perspective: Return On Invested CapitalMarch 17, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Aveanna Healthcare Holdings (AVAH)See More Headlines AVAH Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVAH Company Calendar Last Earnings3/16/2023Today6/03/2023Next Earnings (Estimated)8/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Home health care services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AVAH CUSIPN/A CIK1832332 Webwww.aveanna.com Phone770-441-1580FaxN/AEmployees3,700Year FoundedN/APrice Target and Rating Average Stock Price Forecast$2.34 High Stock Price Forecast$5.00 Low Stock Price Forecast$1.00 Forecasted Upside/Downside+79.0%Consensus RatingHold Rating Score (0-4)1.88 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($3.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-662,030,000.00 Net Margins-39.89% Pretax Margin-40.04% Return on Equity-19.78% Return on Assets-1.04% Debt Debt-to-Equity Ratio5.63 Current Ratio0.82 Quick Ratio0.82 Sales & Book Value Annual Sales$1.79 billion Price / Sales0.14 Cash Flow$3.97 per share Price / Cash Flow0.33 Book Value($0.19) per share Price / Book-6.89Miscellaneous Outstanding Shares188,860,000Free Float175,828,000Market Cap$247.41 million OptionableNot Optionable Beta0.79 Key ExecutivesMr. Rodney D. Windley (Age 74)Exec. Chairman Comp: $1.5MMr. Tony Strange (Age 59)CEO & Director Comp: $1.5MMr. David Afshar CPA (Age 50)Chief Financial Officer Comp: $701.4kMr. Jeffrey S. Shaner (Age 49)Chief Operating Officer Comp: $964.25kMr. Shannon L. Drake (Age 46)Gen. Counsel & Chief Legal Officer Comp: $601.31kMr. Ed Reisz (Age 63)Chief Admin. Officer Mr. Patrick A. Cunningham (Age 66)Chief Compliance Officer Ms. Beth Rubio (Age 65)Chief Clinical Officer Ms. Korey HinzPres of Medical SolutionsMr. Robert RadicsPres of Home Health & HospiceMore ExecutivesKey CompetitorsEnhabitNYSE:EHABPulse BiosciencesNASDAQ:PLSEVaxxinityNASDAQ:VAXXSpectrum PharmaceuticalsNASDAQ:SPPIVerrica PharmaceuticalsNASDAQ:VRCAView All CompetitorsInsiders & InstitutionsVictor F GanziBought 3,200 shares on 6/1/2023Total: $3,776.00 ($1.18/share)Victor F GanziBought 1,758 shares on 5/30/2023Total: $2,004.12 ($1.14/share)Putnam Investments LLCSold 37,800 shares on 5/22/2023Ownership: 0.608%JPMorgan Chase & Co.Bought 8,905 shares on 5/18/2023Ownership: 0.018%Geode Capital Management LLCBought 136,968 shares on 5/16/2023Ownership: 0.520%View All Insider TransactionsView All Institutional Transactions AVAH Stock - Frequently Asked Questions Should I buy or sell Aveanna Healthcare stock right now? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aveanna Healthcare in the last twelve months. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AVAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVAH, but not buy additional shares or sell existing shares. View AVAH analyst ratings or view top-rated stocks. What is Aveanna Healthcare's stock price forecast for 2023? 8 equities research analysts have issued 12 month price objectives for Aveanna Healthcare's stock. Their AVAH share price forecasts range from $1.00 to $5.00. On average, they predict the company's share price to reach $2.34 in the next twelve months. This suggests a possible upside of 79.0% from the stock's current price. View analysts price targets for AVAH or view top-rated stocks among Wall Street analysts. How have AVAH shares performed in 2023? Aveanna Healthcare's stock was trading at $0.78 at the start of the year. Since then, AVAH stock has increased by 67.9% and is now trading at $1.31. View the best growth stocks for 2023 here. Are investors shorting Aveanna Healthcare? Aveanna Healthcare saw a increase in short interest in May. As of May 15th, there was short interest totaling 2,920,000 shares, an increase of 33.9% from the April 30th total of 2,180,000 shares. Based on an average daily volume of 454,100 shares, the days-to-cover ratio is currently 6.4 days. Approximately 6.0% of the shares of the stock are sold short. View Aveanna Healthcare's Short Interest. When is Aveanna Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023. View our AVAH earnings forecast. How were Aveanna Healthcare's earnings last quarter? Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) released its quarterly earnings data on Thursday, March, 16th. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.02. The company earned $451.15 million during the quarter, compared to the consensus estimate of $448.17 million. Aveanna Healthcare had a negative net margin of 39.89% and a negative trailing twelve-month return on equity of 19.78%. What ETF holds Aveanna Healthcare's stock ? Invesco Raymond James SB-1 Equity ETF holds 331,073 shares of AVAH stock, representing 0.35% of its portfolio. What guidance has Aveanna Healthcare issued on next quarter's earnings? Aveanna Healthcare updated its FY 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.84B-, compared to the consensus revenue estimate of $1.85 billion. When did Aveanna Healthcare IPO? (AVAH) raised $478 million in an initial public offering on Thursday, April 29th 2021. The company issued 38,200,000 shares at $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers. What is Aveanna Healthcare's stock symbol? Aveanna Healthcare trades on the NASDAQ under the ticker symbol "AVAH." Who are Aveanna Healthcare's major shareholders? Aveanna Healthcare's stock is owned by a number of institutional and retail investors. Top institutional investors include Principal Financial Group Inc. (1.70%), BlackRock Inc. (1.60%), Putnam Investments LLC (0.61%), Geode Capital Management LLC (0.52%), State Street Corp (0.44%) and Barclays PLC (0.04%). Insiders that own company stock include David Afshar, Jeff Shaner, Patrick A Cunningham, Steven E Rodgers, Tony Strange and Victor F Ganzi. View institutional ownership trends. How do I buy shares of Aveanna Healthcare? Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Aveanna Healthcare's stock price today? One share of AVAH stock can currently be purchased for approximately $1.31. How much money does Aveanna Healthcare make? Aveanna Healthcare (NASDAQ:AVAH) has a market capitalization of $247.41 million and generates $1.79 billion in revenue each year. The company earns $-662,030,000.00 in net income (profit) each year or ($3.88) on an earnings per share basis. How many employees does Aveanna Healthcare have? The company employs 3,700 workers across the globe. How can I contact Aveanna Healthcare? Aveanna Healthcare's mailing address is 400 INTERSTATE NORTH PARKWAY STE 1700, ATLANTA GA, 30339. The official website for the company is www.aveanna.com. The company can be reached via phone at 770-441-1580 or via email at ir@aveanna.com. This page (NASDAQ:AVAH) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aveanna Healthcare Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.